FC
BIIB icon

FIC Capital’s Biogen BIIB Stock Holding History

FIC Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$1.4M Sell
4,470
-228
-5% -$67.5K 0.53% 56
2017
Q2 		$1.27M Sell
4,698
-1,160
-20% -$307K 0.52% 59
2017
Q1 		$1.6M Sell
5,858
-375
-6% -$106K 0.71% 46
2016
Q4 		$1.77M Sell
6,233
-1,299
-17% -$385K 0.89% 41
2016
Q3 		$2.36M Sell
7,532
-70
-0.9% -$20.7K 1.06% 31
2016
Q2 		$1.84M Sell
7,602
-126
-2% -$33.2K 0.87% 38
2016
Q1 		$2.01M Sell
7,728
-1,065
-12% -$281K 0.97% 36
2015
Q4 		$2.69M Sell
8,793
-1,325
-13% -$381K 1.19% 25
2015
Q3 		$2.95M Buy
10,118
+3,675
+57% +$1.21M 1.39% 23
2015
Q2 		$2.6M Buy
6,443
+1,195
+23% +$480K 1.03% 32
2015
Q1 		$2.22M Buy
5,248
+3,280
+167% +$1.29M 0.84% 38
2014
Q4 		$668K Buy
1,968
+145
+8% +$46.9K 0.26% 96
2014
Q3 		$603K Hold
1,823
– – 0.24% 100
2014
Q2 		$575K Hold
1,823
– – 0.22% 109
2014
Q1 		$558K Hold
1,823
– – 0.23% 109
2013
Q4 		$510K Buy
1,823
+22
+1% +$5.69K 0.23% 120
2013
Q3 		$434K Hold
1,801
– – 0.22% 120
2013
Q2 		$388K Buy
+1,801
New +$385K 0.25% 105

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FIC Capital's BIIB Position: Q3 2017 in Review

FIC Capital reduced its Biogen (BIIB) stake by 4.9% in Q3 2017, selling an estimated $67.5K and leaving 4,470 shares worth $1.4M. The position accounts for 0.53% of the portfolio, ranked #56.

FIC Capital first reported a position in BIIB in Q2 2013 and has held it in 18 quarters since. The position peaked at $2.95M in Q3 2015. 1,014 funds tracked by Wall St. Rank hold BIIB as of Q3 2017.

  • FIC Capital held 4,470 shares of Biogen worth $1.4M as of Q3 2017.
  • FIC Capital sold 228 Biogen shares in Q3 2017, an estimated $67.5K.
  • Biogen made up 0.53% of FIC Capital's portfolio in Q3 2017, its #56 holding.
  • FIC Capital first reported a position in Biogen in Q2 2013 and has held it in 18 quarters since.
  • FIC Capital's Biogen position peaked at $2.95M in Q3 2015.
  • 1,014 funds tracked by Wall St. Rank held Biogen as of Q3 2017.

Based on FIC Capital's 13F filing for Q3 2017, filed 14 Nov 2017.